Form 4: Amylyx Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Camille L Bedrosian, Chief Medical Officer of Amylyx Pharmaceuticals, Inc., sold 10,028 shares of common stock on September 10, 2026.
Summary
- Open-market sale: disposed of 7,947 Common Stock at $32.21 ($256,004) on September 10, 2026; holds 280,145 after (Direct).
- Open-market sale: disposed of 2,081 Common Stock at $33.09 ($68,864) on September 10, 2026; holds 278,064 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $324,868 of stock on the open market.
Insider Transactions
Camille L Bedrosian — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Open-market sale | Common Stock | 7,947 | $32 | $256.0K | 280,145 |
| 2026-09-10 | Open-market sale | Common Stock | 2,081 | $33 | $68.9K | 278,064 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Open-market sale (7,947 shares) |
| 2026-09-10 | Open-market sale (2,081 shares) |
Keywords
insider transaction, Form 4, AMLX, Amylyx Pharmaceuticals, Inc., bearish, Camille L Bedrosian
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.